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(U of C) Medicine.As she said in writing about Theodore Puck in 2006, ‘‘it is
impossible to write a comprehensive obituary of [Janet
Rowley] in less than a dozen pages.1’’ Leading pioneer in
cancer research and matriarch of cancer genetics and cyto-
genetics, Janet Davison Rowley, M.D. (Figure 1), died at her
home from complications of ovarian cancer on December
17, 2013. How ironic that a woman whose numerous can-
cer research discoveries led to lifesaving treatments for so
many cancer patients succumbed to cancer. Dr. Rowley
joined the American Society of Human Genetics (ASHG)
in 1963 and was an active member; she served on the
board of directors from 1985 to 1988 and as president
from 1992 to 1993. ‘‘Janet Rowley’s work established that
cancer is a genetic disease,’’ said Mary-Claire King, profes-
sor of genetics and medicine in the Division of Medical
Genetics at the University of Washington and past presi-
dent (2012) of ASHG. ‘‘She demonstrated that mutations
in critical genes lead to specific forms of leukemia and
lymphoma and that one can determine the form of cancer
present in a patient directly from the genetic changes
in the cancer. We are still working from her paradigm.’’
For her groundbreaking studies in cancer genetics and
cytogenetics, in 1991 Dr. Rowley was corecipient (with
Alfred G. Knudson Jr., M.D., Ph.D.) of the Allen Award,
the preeminent prize awarded by ASHG. At the 2009
ASHG meeting, Dr. Rowley received the prestigious Peter
and Patricia Gruber Foundation Genetics Prize, awarded
for trailblazing research that ‘‘provides new models that
inspire and enable fundamental shifts in knowledge and
culture.’’ An excellent writer, she made her earliest contri-
bution to the American Journal of Human Genetics with a
book review in 1974. She was published thrice more in
The Journal: in 1994 for her 1993 presidential address,2 in
2003 for her introductory speech for Albert de la Chapelle
(the 2002 William Allen Award winner),3 and in 2006 for
her memorial to Theodore Puck.1
Professors Janet Rowley and Felix Mitelman cofounded
and served as co-editors-in-chief of the journal Genes,
Chromosomes & Cancer for 25 years. Genes, Chromosomes
& Cancer continues to provide rapid publication of high-
quality studies in cancer genetics and cytogenetics,
advancing the fields that Dr. Rowley shaped.
The only child of Ethel and Hurford Davison, Janet
Davison was born on April 5, 1925, in New York City.
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The Am(U of C), moved back to the south side of Chicago to accept
positions as educators when Janet was a toddler. After 2
years of high school, Janet earned a scholarship to enroll
in the Hutchins College at the U of C, which combined
the last 2 years of high school with the first 2 years of
college. ‘‘The U of C,’’ she later recalled, ‘‘taught me to stick
to my convictions if I really thought that I was correct,
even when others disagreed.’’ Janet completed her college
degree at the U of C in 1944 and was accepted into the U of
C medical school but had to wait to matriculate because
the quota for women—three per class of 65—was already
filled. ‘‘So I had to wait 9 months,’’ she said in an interview,
‘‘I was only 19 at the time, so it wasn’t a great tragedy.’’ At
the age of 23, Janet Davison graduated from medical
school, and the next day, she married fellow medical
student Donald Rowley, M.D., who would become an
eminent professor of pathology at the U of C. Dr. Janet
Rowley completed her internship at the United States Pub-
lic Health Service’s Marine Hospital in Chicago in 1951.
She spent the next 20 years raising her family, composedof Public Health, Pittsburgh, PA 15261, USA; 2Department of Pathology,
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Figure 2. Dr. Rowley at Her Microscope
Courtesy of the U of C Medicine.of four sons, while working part time at various Chicago
clinics, including one that provided specialized care for
children with trisomy 21 (Down syndrome). The Rowley
family spent a year at Oxford University while Donald
did a sabbatical and Janet learned the newly developed
techniques of chromosome analysis from Marco Fraccaro.
When Janet Rowley returned to Chicago in 1962, her
colleague and mentor, Leon Jacobson, M.D., suggested
that she apply her new knowledge to study the chromo-
somes from patients with leukemia. He offered a lab bench,
a microscope, and a small salary to examine chromosomes
from his leukemia patients. For the next decade, she
labored over the microscope in the search for consistent
chromosome abnormalities amid the seeming genetic
chaos of leukemic cells, a daunting task in the era prior
to chromosome banding (Figure 2).
Knowing Dr. Janet Rowley as we do, it is not surprising
that she made her first big scientific discovery at home. A
second sabbatical in Oxford, this time withWalter Bodmer
from 1970 to 1971, enabled her to learn new fluorescent
staining techniques to highlight chromosomal bands and
facilitate differentiation between the various chromo-
somes. Dr. Rowley began to photograph the banded chro-
mosomes from leukemia patients by using the fluorescence
microscope. She would take the pictures home to examine.
Her children often teased her about getting paid to play
with paper dolls as she sat at their dining room table while
using surgical scissors to cut each chromosome out of the
photographs and carefully arranging them in pairs. In
the spring of 1972, in her Hyde Park home, Rowley ‘‘lined
up the chromosomes from leukemia cells on a table and
told [her] kids not to sneeze.’’ She noticed that the chromo-
somes from a patient with acute myeloid leukemia (AML)
had two abnormalities. Chromosomes 8 and 21 appeared
to have made a trade. The bottom of one chromosome806 The American Journal of Human Genetics 94, 805–808, June 5, 221 had broken off and moved to the bottom of one
chromosome 8, and the bottom of that chromosome 8
had moved to the bottom of that chromosome 21—an
apparently reciprocal exchange we now know as t(8;21)
(q22;q22). When she looked at more patients with this
same kind of leukemia, she saw the same translocation.
Assuming that this finding had already been published,
she went to the library, and to her surprise, it hadn’t
been reported in the literature. The realization that she
had discovered that leukemia was associated with a genetic
alteration was reportedly ‘‘one of the greatest moments’’ in
her life, but like most breakthroughs, her finding was
greeted with skepticism by the scientific community. Later
that year, Dr. Rowley noticed that patients with another
form of leukemia, chronic myelogenous leukemia (CML),
had a different translocation. The bottom of one chromo-
some 22 had been exchanged for a piece of the bottom
of one chromosome 9. This translocation, which we now
know as t(9;22)(q34;q11.2), causes important genes that
regulate cell growth and division to no longer be in their
normal position, resulting in the uncontrolled cellular pro-
liferation that is cancer. The observation of two consistent
translocations in leukemia, one in AML and one in CML
(both published in 1973), argued that such translocations
were tied to specific types of leukemia.4,5 Yet, because of
chromosomal instability, variant translocations, and addi-
tional chromosomal alterations in patients with leukemia,
many scientists remained skeptical. ‘‘It was generally
thought that chromosome abnormalities were a conse-
quence of the cancer, not the cause,’’ Rowley recalled.
In 1977, Rowley and colleagues identified a third consis-
tent chromosomal alteration in leukemia, the t(15;17)
(q24.1;q21) translocation, which causes acute promyelo-
cytic leukemia, a rare disease but one in which every pa-
tient has the same genetic rearrangement.6 ‘‘That made
me a believer,’’ she later recalled. ‘‘That was the frosting
on the cake.’’
Following her lead that specific translocations defined
specific forms of cancer, scientists around the world joined
the search for chromosomal alterations in cancer. Others
used the translocations as roadmaps to find specific genes
disrupted by chromosome damage, thus opening up the
current era of cancer genetics. By 1990, more than 70
translocations had been identified and linked to different
cancers. ‘‘This was a time of excitement and wonder that
is hard to describe,’’ Dr. Rowley wrote in an essay. At age
47, after publishing the AML and CML studies, her 19th
and 20th publications, respectively,4,5 her 21st publication
was a report on chromosomal patterns in myelocytic leu-
kemia in the New England Journal of Medicine.7 Her career
skyrocketed. Her resume now lists 509 publications in lead-
ing scientific journals. More recent discoveries include
cloning a gene rearrangement that occurs in leukemias
seen in infants and the recognition that deletions of
chromosomes 5 and 7 are associated with therapy-related
leukemia in patients previously treated with particular
anticancer drugs. Janet Rowley rose quickly through the014
Figure 3. Authors Susanne Gollin, Left, and Shalini Reshmi,
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Figure 4. Dr. Rowley on Her Bicycle at the U of C
Courtesy of the U of C Medicine.ranks at the U of C from research associate (assistant pro-
fessor) in 1962 to associate professor in 1969, professor
in 1977, and distinguished service professor in 1984.
Although she should have retired at some point around
age 70, Dr. Rowley accepted the position of InterimDeputy
Dean for Science in the Division of the Biological Sciences
at the U of C from January 2001 to November 2002. She
continued to be active in science and traveled extensively
to present lectures and receive awards.
The awards began in the early 1980s with the Lasker
Award and the National Medal of Science, the nation’s
highest scientific honor, in 1998. Others included the
Presidential Medal of Freedom, America’s highest civilian
honor, in 2009; the Lifetime Achievement Award from
the American Association for Cancer Research in 2010;
the Japan Prize for Healthcare and Medical Technology
in 2012; and the Albany Medical Center Prize in 2013.
Janet Rowley received honorary doctor of science degrees
from 14 institutions, including Oxford, Harvard Univer-
sity, Yale University, the University of Pennsylvania, and
Dartmouth College. Dr. Rowley was elected as a member
of numerous scientific and honorary societies, including
the National Academy of Sciences, the Institute of Medi-
cine, the American Philosophical Society, and the Amer-
ican Academy of Arts & Sciences.
Janet Rowley was not only a distinguished researcher
and steadfast colleague but also an attentive and encour-
aging mentor and often a mother figure to her trainees,
staff, and others whom she took under her wing (Figure 3).
She routinely advised young (and older) investigators
not to give up. ‘‘Take risks,’’ she had said. ‘‘Do something
different if it looks interesting. I didn’t do anything note-
worthy until I was 50. Success often involves a great deal of
luck. Some people don’t like to hear that because it means
there are things out of their control. But that’s the way it
is.’’ She would often sign emails, ‘‘Good luck!! Janet.’’ Janet
Rowley mentored nearly 100 graduate students, postdocs,
and fellows and gave anyone interested in science an op-
portunity to carry out research projects in her laboratory,
irrespective of funding, because she would always find
funding to support aspiring students. No matter how
busy she was, when a trainee needed a letter of reference,The AmDr. Rowley was always there for him or her. She treated
every human being with respect, regardless of their lot in
life. She played an important role on national ethics and
cancer advisory committees by clearly stating her views
on controversial matters, such as stem cell research, and
making clear that funding for ‘‘observation-driven’’ cancer
research like her own should also be funded in this era of
funding for only ‘‘hypothesis-driven’’ science.
An avid gardener, Dr. Rowley spent her rare free mo-
ments tending to her urban flower and vegetable garden
at her home near the U of C campus. Her garden was the
place where she claimed to have done some of her best
thinking. Dr. Rowley would stop in her tracks midconver-
sation to remove a weed from a neighbor’s garden. The
Janet Rowley Memorial Garden at the west end of Bond
Chapel near the center of the U of C campus is sure to
remain weed free. Dr. Rowley also enjoyed her indoor
garden in her sunroom at home. We often spoke of our
mutual love of orchid plants. Her other interests included
the opera and traveling worldwide to hike, camp, observe
wildlife, and become acquainted with the indigenous peo-
ples. Dr. Rowley exercised by swimming in Lake Michigan
and in bodies of water around the world, including swim-
ming in the Pacific Ocean with her grandchildren during
the 2009 ASHG meeting in Hawaii. She continued to bicy-
cle daily from her Hyde Park home to her laboratory into
her late 80s, regardless of the weather conditions (Figure 4).
Needless to say, Dr. Rowley had limitless energy. During
a meeting on fluorescence in situ hybridization in Colo-
rado, upon returning to the lodge after a day of skiing,
Dr. Rowley was looking for companions to join her on
a snowshoeing expedition. Dr. Rowley also enjoyed
spending time with her family at their cottage in the Porter
Beach community, overlooking Lake Michigan. Additions
to their cottage were built to accommodate their growing
family of grandchildren, and some of the furniture was
designed and built by Dr. Rowley’s husband. There, sur-
rounded by the Indiana Dunes State Park and overlooking
the Indiana Dunes National Lakeshore with a clear view oferican Journal of Human Genetics 94, 805–808, June 5, 2014 807
the downtown Chicago skyline, she gardened, swam in
the lake, read while sitting on the deck, and hosted guests
for recreation, relaxation, and delicious home-cooked
meals.
Dr. Rowley remained a proud yet humble woman with a
keen sense of style and grace and a terrific sense of humor.
She often shunned the limelight and deflected accolades to
her coworkers by indicating that her later research findings
were the result of a team effort. According to speakers at
her memorial service, including her son Robert, Dr. Rowley
apologized to her colleague for putting him in the difficult
position of having to give her the diagnosis of ovarian can-
cer. She donated her cancer tissue to science in the hope
that researchers might learn from it so that someday,
they might be able to prolong the life of other women
afflicted with this devastating disease. Near the end of
her life, as remembered by her son David at her memorial
service, she was barely able to walk up to the dais to accept
the Partners in Discovery Award from the Women’s Board
of the U of C Cancer Research Foundation in November
2013, but she proceeded to put on her ‘‘game face’’ to rally
for more funding for scientific research.
Dr. Rowley’s beloved husband, Donald, died in March
2013. Although they had experienced the loss of a son in
an accident at Porter Beach, the loss of her husband of 65
years was extremely difficult for her. Dr. Rowley is survived
by three sons, David, Robert, and Roger, and five grandchil-
dren, Jason, Jenny, Gia, Anra, and Ian. David Rowley said,
‘‘Bothmy parents served as exemplary role models for their
approaches to science, to life, to others, and to family.’’
‘‘Mymother was an inspiration to all of her family through
her generosity and her caring and doing whatever was in
her power to help each of us achieve our own individual
goals. She will be dearly missed by her family, including
five grandchildren.’’ David, you and your family should
know that Janet Davison Rowley will be dearly missed not
only by her family but also by her friends, neighbors, col-
leagues, trainees, and countless people whose lives she808 The American Journal of Human Genetics 94, 805–808, June 5, 2touched directly and indirectly by her contributions to
science, medicine, and humanity. As Peter Aplan wrote in
an email exchange among editors and editorial boardmem-
bers of her beloved journal, Genes, Chromosomes & Cancer,
‘‘Although we are all poorer for this loss, we are all richer
for her life.’’ Further, as BrianDruker, director of theOregon
Health & Science University Knight Cancer Institute, who
shared the Japan Prize with Janet Rowley for development
of Gleevec said, ‘‘Her spirit will live on in all of the people
who have benefitted from her work.’’Acknowledgments
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